Research and Markets (http://www.researchandmarkets.com/research/q2tjt3/osteoporosis) has announced the addition of the "Osteoporosis - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteoporosis and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Osteoporosis Overview
- Therapeutics Development
- Pipeline Products for Osteoporosis - Overview
- Pipeline Products for Osteoporosis - Comparative Analysis
- Osteoporosis - Therapeutics under Development by Companies
- Osteoporosis - Therapeutics under Investigation by Universities/Institutes
- Osteoporosis - Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Osteoporosis - Products under Development by Companies
- Osteoporosis - Products under Investigation by Universities/Institutes
- Osteoporosis - Companies Involved in Therapeutics Development
- Alethia Biotherapeutics Inc.
- Alize Pharma SAS
- Alkem Laboratories Ltd.
- Amgen Inc.
- Amura Holdings Limited
- Arcarios BV
- Astellas Pharma Inc.
- Bone Medical Limited
- Bone Therapeutics SA
- Caladrius Biosciences, Inc.
- Chronos Therapeutics Limited
- Chugai Pharmaceutical Co., Ltd.
- Corium International, Inc.
- Galapagos NV
- Glide Pharmaceutical Technologies Limited
- Hanmi Pharmaceuticals, Co. Ltd.
- Haoma Medica Ltd.
- IMMD Inc.
- Lotus Pharmaceutical Co., Ltd.
- Lupin Limited
- Medivir AB
- Merck & Co., Inc.
- Mereo Biopharma Group Limited
- Merrion Pharmaceuticals Plc
- Novartis AG
- Omeros Corporation
- Oncobiologics, Inc.
- Oscotec Inc.
- Osteologix Holdings Plc
- Pantarhei Bioscience BV
- Paras Biopharmaceuticals Finland Oy
- Pfizer Inc.
- PhytoHealth Corporation
- Sumitomo Dainippon Pharma Co., Ltd.
-
Takeda Pharmaceutical Company Limited
For more information visit http://www.researchandmarkets.com/research/q2tjt3/osteoporosis
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160122005610/en/
